| SC 13G | 2020-02-11 | VANGUARD GROUP INC | INOVIO PHARMACEUTICALS, INC. | 5,052,394 | 5.0% | EDGAR |
| SC 13G/A | 2020-02-10 | WASATCH ADVISORS INC | INOVIO PHARMACEUTICALS, INC. | - | - | EDGAR |
| SC 13G/A | 2020-02-05 | BlackRock Inc. | INOVIO PHARMACEUTICALS, INC. | 7,634,600 | 7.6% | EDGAR |
| SC 13G | 2019-02-14 | WASATCH ADVISORS INC | INOVIO PHARMACEUTICALS, INC. | - | - | EDGAR |
| SC 13G/A | 2019-02-04 | BlackRock Inc. | INOVIO PHARMACEUTICALS, INC. | 7,251,925 | 7.6% | EDGAR |
| SC 13G/A | 2018-01-25 | BlackRock Inc. | INOVIO PHARMACEUTICALS, INC. | 6,627,505 | 7.3% | EDGAR |
| SC 13G/A | 2017-01-25 | BlackRock Inc. | INOVIO PHARMACEUTICALS, INC. | 5,336,496 | 7.2% | EDGAR |
| SC 13G/A | 2016-02-12 | CAPITAL VENTURES INTERNATIONAL | INOVIO PHARMACEUTICALS, INC. | 0 | 0.0% | EDGAR |
| SC 13G/A | 2016-01-26 | BlackRock Inc. | INOVIO PHARMACEUTICALS, INC. | 4,940,893 | 6.9% | EDGAR |
| SC 13G | 2015-05-08 | CAPITAL VENTURES INTERNATIONAL | INOVIO PHARMACEUTICALS, INC. | 4,250,000 | 6.1% | EDGAR |
| SC 13G | 2015-02-02 | BlackRock Inc. | INOVIO PHARMACEUTICALS, INC. | 3,590,287 | 5.9% | EDGAR |
| SC 13G/A | 2014-02-13 | CAPITAL VENTURES INTERNATIONAL | INOVIO PHARMACEUTICALS, INC. | 0 | 0.0% | EDGAR |
| SC 13G/A | 2013-10-10 | MARXE AUSTIN W & GREENHOUSE DAVID M | INOVIO PHARMACEUTICALS, INC. | 6,900,000 | 3.5% | EDGAR |
| SC 13G | 2013-03-15 | CAPITAL VENTURES INTERNATIONAL /E9/ | INOVIO PHARMACEUTICALS, INC. | 9,090,908 | 5.1% | EDGAR |
| SC 13G/A | 2013-01-10 | MARXE AUSTIN W & GREENHOUSE DAVID M | INOVIO PHARMACEUTICALS, INC. | 11,349,354 | 7.6% | EDGAR |
| SC 13G/A | 2012-02-13 | MARXE AUSTIN W & GREENHOUSE DAVID M | INOVIO PHARMACEUTICALS, INC. | 20,393,450 | 14.0% | EDGAR |
| SC 13G | 2011-02-10 | MARXE AUSTIN W & GREENHOUSE DAVID M | INOVIO PHARMACEUTICALS, INC. | 21,130,400 | 16.9% | EDGAR |
| SC 13G | 2011-02-10 | MARXE AUSTIN W & GREENHOUSE DAVID M | INOVIO PHARMACEUTICALS, INC. | 21,130,400 | 16.9% | EDGAR |
| SC 13D | 2009-06-10 | COLLINS MORTON | INOVIO BIOMEDICAL CORP | 8,000,000 | 9.3% | EDGAR |
| SC 13D | 2009-06-10 | Kim Jong Joseph | INOVIO BIOMEDICAL CORP | 15,081,232 | 16.9% | EDGAR |